BBO-11818 in Adult Subjects With KRAS Mutant Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Janssen Research & Development, LLC
Seagen Inc.
Eli Lilly and Company
Pfizer
RemeGen Co., Ltd.
Pfizer
M.D. Anderson Cancer Center
Amgen
AstraZeneca
Eli Lilly and Company
Janssen Research & Development, LLC
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
AstraZeneca
Rutgers, The State University of New Jersey
H. Lee Moffitt Cancer Center and Research Institute
AstraZeneca
BioNTech SE
Tesaro, Inc.
University Health Network, Toronto
AbbVie
Jemincare
Peking University Cancer Hospital & Institute
Shanghai Junshi Bioscience Co., Ltd.
DEKA Biosciences
Daiichi Sankyo
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Inspirna, Inc.
UNC Lineberger Comprehensive Cancer Center
Blueprint Medicines Corporation
AstraZeneca
Arcus Biosciences, Inc.
Eli Lilly and Company
Taiho Pharmaceutical Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Shanghai Jiao Tong University School of Medicine
Emory University
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Cantargia AB
Blueprint Medicines Corporation
National Cancer Institute (NCI)
Aileron Therapeutics, Inc.
Merck Sharp & Dohme LLC
Novartis
Bristol-Myers Squibb
Emory University
BioNTech SE
AIDS Malignancy Consortium